Clinical Trial Update: A Study of the Efficacy and Safety of Flumatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase. [Phase 4]

View source ↗

Summary

A phase 4 clinical trial evaluating the efficacy and safety of flumatinib in newly diagnosed chronic myeloid leukemia in chronic phase.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia Chronic Phase

Drugs mentioned

• Flumatinib (flumatinib)

Snippet

Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. | Conditions: CML, Chronic Phase | Phase 4 | Status: UNKNOWN